These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3905642)

  • 21. Hypothalamic microdialysis of mazindol causes anorexia with increase in synaptic serotonin in rats.
    Shimizu N; Take S; Hori T; Oomura Y
    Physiol Behav; 1991 Jan; 49(1):131-4. PubMed ID: 2017466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lateral hypothalamus neuron responses to electroosmotic 2-deoxy-D-glucose.
    Shiraishi T; Simpson A
    Brain Res Bull; 1982 Jun; 8(6):645-51. PubMed ID: 7139357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ghrelin on hypothalamic glucose responding neurons in rats.
    Chen X; Ge YL; Jiang ZY; Liu CQ; Depoortere I; Peeters TL
    Brain Res; 2005 Sep; 1055(1-2):131-6. PubMed ID: 16084498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of mazindol on food intake in ventromedial hypothalamic lesioned rats and glucose absorption in rats.
    Inoue S; Tsuchiya M; Takamura Y
    Int J Obes; 1987; 11 Suppl 3():63-9. PubMed ID: 3440693
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of mazindol on feeding behaviour and on noradrenergic function of various parts of the rat brain.
    Halmy L; Nyakas C; Walter J
    Acta Physiol Acad Sci Hung; 1982; 59(4):341-7. PubMed ID: 7170986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake.
    Chen X; Dong J; Jiang ZY
    Regul Pept; 2012 Aug; 177(1-3):21-6. PubMed ID: 22561448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemistry and pharmacology of mazindol.
    Gogerty JH; Trafold JH
    Triangle; 1976; 15(1):25-36. PubMed ID: 960214
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological analysis of a new anorexic substance: 5-hydroxy-5(4'-chlorophenyl)-2, 3-dihydro-5H-imidazo-(2, 1-a) isoindole (Mazindol).
    Gogerty JH; Penberthy C; Iorio LC; Trapold JH
    Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):285-307. PubMed ID: 1171662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the ventromedial hypothalamic orexin-1 receptors in regulation of gastric Acid secretion in conscious rats.
    Eliassi A; Nazari M; Naghdi N
    J Neuroendocrinol; 2009 Mar; 21(3):177-82. PubMed ID: 19207823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin acting as a modulator of feeding through the hypothalamus.
    Oomura Y; Kita H
    Diabetologia; 1981 Mar; 20 Suppl():290-8. PubMed ID: 6262171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The peripheral actions of antiobesity drugs.
    Turner P; Bichi LA; Slusarczyk H; Franklin CS
    Int J Obes; 1982; 6(4):411-5. PubMed ID: 6752061
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone.
    Anderson W; Molina E; Rentz J; Hirschowitz BI
    J Pharmacol Exp Ther; 1982 Sep; 222(3):617-22. PubMed ID: 6809930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of feeding suppression produced by perifornical hypothalamic injection of catecholamines, amphetamines and mazindol.
    Leibowitz SF; Rossakis C
    Eur J Pharmacol; 1978 Dec; 53(1):69-81. PubMed ID: 738361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of [3H]mazindol binding to subhypothalamic areas: involvement in glucoprivic feeding.
    Angel I; Kiss A; Stivers JA; Skirboll L; Crawley JN; Paul SM
    Brain Res Bull; 1986 Dec; 17(6):873-7. PubMed ID: 3801941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of an anorectic agent, AN 448 on weight reduction and plasma lipids.
    Ishikawa T; Nakaya N; Nakamura H; Goto Y
    Keio J Med; 1975 Jul; 24(3):211-8. PubMed ID: 1219154
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of mazindol on carbohydrate and insulin metabolism in obesity.
    Harrison LC; King-Roach AP; Sandy KC
    Metabolism; 1975 Dec; 24(12):1353-65. PubMed ID: 1196130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of specific binding sites for [3H]mazindol in rat hypothalamus: correlation with the anorectic properties of phenylethylamines.
    Angel I; Paul SM
    Eur J Pharmacol; 1985 Jul; 113(1):133-4. PubMed ID: 4043206
    [No Abstract]   [Full Text] [Related]  

  • 39. Aphrodisia with mazindol.
    Friesen LV
    Lancet; 1976 Oct; 2(7992):974. PubMed ID: 62210
    [No Abstract]   [Full Text] [Related]  

  • 40. Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro.
    Angel I; Taranger MA; Claustre Y; Scatton B; Langer SZ
    Life Sci; 1988; 43(8):651-8. PubMed ID: 3261828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.